Literature DB >> 2348502

Audiovestibular functions in rheumatoid arthritis.

R S Kakani1, Y N Mehra, S D Deodhar, S B Mann, S Mehta.   

Abstract

Audiologic, middle ear impedance and vestibular function tests were administered to 25 patients with classical or definite rheumatoid arthritis and 25 normal control subjects of 30 to 50 years age group. Any possible influence of other common causes of hearing loss was avoided by carefully selecting the patients. Six patients had mild sensorineural hearing loss and another had bilateral mixed hearing loss. Results of tone decay test, speech reception threshold, speech discrimination score and short increment sensitivity index tests suggested cochlear pathology being responsible for the sensorineural hearing loss. There was no statistical correlation between hearing loss or otoadmittance abnormality and duration or activity of rheumatoid arthritis or positivity of rheumatoid factor. Electronystagmographic recording of saccades and bithermal caloric induced nystagmus revealed no significant abnormality.

Entities:  

Mesh:

Year:  1990        PMID: 2348502

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  11 in total

1.  Cumulative disease activity predicts incidental hearing impairment in patients with rheumatoid arthritis (RA).

Authors:  Virginia Pascual-Ramos; Irazú Contreras-Yáñez; Paula Rivera-Hoyos; Lorena Enríquez; Jaqueline Ramírez-Anguiano
Journal:  Clin Rheumatol       Date:  2014-01-18       Impact factor: 2.980

2.  Relationship between disease activity and hearing impairment in patients with rheumatoid arthritis compared with controls.

Authors:  Adem Yildirim; Gulseren Surucu; Sedat Dogan; Mehmet Karabiber
Journal:  Clin Rheumatol       Date:  2015-11-28       Impact factor: 2.980

3.  Subjective audiological tests and transient evoked otoacoustic emissions in patients with rheumatoid arthritis: analysis of the factors affecting hearing levels.

Authors:  Oğuzhan Dikici; Nuray Bayar Muluk; Aliye Kapukiran Tosun; Ihsan Unlüsoy
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-10       Impact factor: 2.503

4.  Does rheumatoid arthritis have an effect on audiovestibular tests?

Authors:  Mahmut Özkırış; Zeliha Kapusuz; İlhan Günaydın; Utku Kubilay; İlyas Pırtı; Levent Saydam
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-12       Impact factor: 2.503

5.  Hearing impairment in patients with rheumatoid arthritis: association with anti-citrullinated protein antibodies.

Authors:  Fabrício Silva Lobo; Mario Orlando Dossi; Lígia Batista; Márcia Midori Shinzato
Journal:  Clin Rheumatol       Date:  2016-04-26       Impact factor: 2.980

6.  Study of Auditory function in Rheumatoid Arthritis.

Authors:  V K Poorey; R Khatri
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2001-10

7.  Examination of Hearing in a Rheumatoid Arthritis Population: Role of Extended-High-Frequency Audiometry in the Diagnosis of Subclinical Involvement.

Authors:  Mar Lasso de la Vega; Ithzel Maria Villarreal; Julio Lopez-Moya; Jose Ramon Garcia-Berrocal
Journal:  Scientifica (Cairo)       Date:  2016-04-27

8.  Vestibular evoked myogenic potentials in patients with rheumatoid arthritis.

Authors:  Nahid Heydari; Fahimeh Hajiabolhassani; Jamileh Fatahi; Shafieh Movaseghi; Shohreh Jalaie
Journal:  Med J Islam Repub Iran       Date:  2015-06-06

9.  Evaluation of Audiometric Test Results to Determine Hearing Impairment in Patients with Rheumatoid Arthritis: Analysis of Data from the Korean National Health and Nutrition Examination Survey.

Authors:  Hyemin Jeong; Young-Soo Chang; Sun Young Baek; Seon Woo Kim; Yeong Hee Eun; In Young Kim; Jaejoon Lee; Eun-Mi Koh; Hoon-Suk Cha
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

10.  Sensorineural Hearing Impairment and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients Without Traditional Cardiovascular Risk Factors.

Authors:  Hector Macias-Reyes; Sergio Duran-Barragan; Cynthia R Cardenas-Contreras; Cesar G Chavez-Martin; Eduardo Gomez-Bañuelos; Rosa E Navarro-Hernandez; Carlos O Yanowsky-Gonzalez; Laura Gonzalez-Lopez; Jorge I Gamez-Nava; Monica Vazquez-Del Mercado
Journal:  Arch Rheumatol       Date:  2016-04-06       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.